Clinical Scorecard: 30 Minutes to Relief? Real-World Data Say Yes
At a Glance
| Category | Detail |
|---|---|
| Condition | Dysmenorrhea |
| Key Mechanisms | Hyoscine butylbromide (HBB) and paracetamol combination for pain relief. |
| Target Population | Adult women experiencing menstrual pain. |
| Care Setting | Noninterventional study conducted via an online patient platform. |
Key Highlights
- Median time to meaningful pain relief was 38 minutes.
- 91% of patients achieved a clinically meaningful response within 4 hours.
- Pain intensity decreased significantly at all postdose assessments.
- 96% of patients reported at least one dysmenorrhea symptom at baseline, reduced to 70% at 4 hours.
- Over 90% of patients were satisfied or very satisfied with treatment effectiveness.
Guideline-Based Recommendations
Diagnosis
- Assess menstrual pain severity using numeric rating scale (NRS).
Management
- Consider HBB 10 mg and paracetamol 500 mg for self-treatment of dysmenorrhea.
Monitoring & Follow-up
- Monitor pain intensity and symptom reduction at multiple time points post-treatment.
Risks
- Be aware of potential nonserious treatment-emergent adverse events.
Patient & Prescribing Data
Women aged around 34 years with moderate to severe menstrual pain.
Patients typically used 1 to 2 tablets per day over a median of 3 days during menstruation.
Clinical Best Practices
- Encourage patients to report pain intensity using NRS.
- Educate patients on the safe use of HBB and paracetamol combination.
- Consider patient satisfaction as a key outcome measure.
References
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.
